Category Innovation/ R&D

UN Assembly Tackles Role Of Technology And Innovation In Sustainable Development

Governments and the private sector must work more closely together in the area of technology and innovation to make the United Nations Sustainable Development Goals (SDGs) a reality by 2030, government and major tech company officials said at today’s UN high-level event in New York. Today’s development problems won’t be solved with yesterday’s solutions but by all stakeholders – governments, civil society, youth, businesses and academia – working together, said General Assembly President Miroslav Lajčák. Everyone must have “fair access to technologies and innovations” and to training, he said.

CSIS Report Finds Tech, Innovation Partnership Opportunities In Developing Countries

"There are clear opportunities to accelerate and expand opportunity through innovation and technology around the world," finds a new report from the Washington, DC-based Center for Strategic and International Studies (CSIS). And the United States - and any other developed country - would do well to position itself as a "partner of choice for developing countries that want to transform their economies through science, technology and innovation," it said. But strong intellectual property rights and a business-friendly environment are a necessity, it argues.

Key IP Delegates In Geneva – Fully Updated!

Geneva, Switzerland is the gathering point for the world's governments to set international policy and practices relating to intellectual property rights, as they cut across many of the public policy issues of the day (eg innovation, trade, internet, health, food), including at the World Intellectual Property Organization, World Trade Organization and World Health Organization. Everyone has a stake in what governments and their stakeholders do in these venues. But who do you talk to in order to get your message through? Now Intellectual Property Watch has fully updated its unique list of the diplomats representing many of the key nations in those institutions in Geneva. Available here for subscribers only!

Law Enforcement, Industry Hold Event Against IP Crime At UN

NEW YORK – An event of international law enforcement, security experts and industry this week at the United Nations headquarters in New York aimed at building strategies against a wide range of intellectual property crime worldwide. At the event, a senior United States official discussed plans to expand a program of US IP experts abroad.

Case Study – Building Effective IP Coverage Efficiently Within An International Engineering Conglomerate

This article describes how to build up an effective IP coverage for an international industrial conglomerate by defining the basic IP shield construction for all group companies, setting up IP generation programs and developing an IP focus while doing this efficiently by engaging the management into the IP decisions and managing the mix of internal and external IP service resources.

Fifa Rahman

Malaysia Inclusion In Gilead Voluntary Licence – A Product Of Compulsory Licence Pressure

Gilead’s announcement today that they would include four middle-income countries (Malaysia, Thailand, Belarus, Ukraine) in their sofosbuvir voluntary licence was a welcome surprise, and will enable millions access to their highly effective, but exorbitantly priced, drug. The decision to include these countries, however, no doubt is a response to increasing pressure from within these countries to either issue a compulsory licence (CL) or a government use licence (GUL), invalidate the sofosbuvir patents, or block data exclusivity for the drug.

Access To Medicines Foundation Details Methodology For 2018 AMR Benchmark

The Amsterdam-based Access to Medicines Foundation today published the methodology it will use for its 2018 framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance, addressing the rising the global problem of overuse of antibiotics leading to resistance with few new ones in the pipeline.

Report Shows Benefits Of US Investment In Global Health R&D

A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases.

Report From WHO Fair Pricing Meeting Shows Balanced Discussion

A wide range of governments and stakeholders attended a closed meeting in the Netherlands in May to address the ongoing problem of pricing medicines to pay for research and the resulting lack of affordability of those medicines. The report from the World Health Organization-led meeting shows a range of points were made by participants and signals a move to change the global policy.